Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 9,229-9,240 of 10,592
Other study type icon
CompletedNCT03393390

Cognition and Control in Youths

This study exists to compare options and see whether the medication Cognition offers something meaningfully different. Researchers are trying to understand whether the medication Cognition can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 6 Years to 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
ADHD
Drug study icon
CompletedNCT05021640

DCR-AUD in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.From 21 Years to 65 Years
Countries
United States
Sponsor
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Condition
Addiction
Drug study icon
TerminatedNCT04722666

MIJ821 for depression

This study was terminated in the United States, in Canada, in Argentina, .... It is testing MIJ821 for depression.

In United States
Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Argentina, ...
Sponsor
Novartis Pharmaceuticals
Condition
Depression, Suicidality
Behavioral study icon
CompletedNCT03751280

Efficacy of PEAR-004 in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT05454410

MIJ821 for treatment-resistant depression

This study is completed in the United States, in Japan, in Poland, .... It is testing MIJ821 for treatment-resistant depression.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Japan, Poland, ...
Sponsor
Novartis Pharmaceuticals
Condition
Depression
Drug study icon
TerminatedNCT04933916

EMB-001 as a Potential Smoking Cessation Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
Embera NeuroTherapeutics, Inc.
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.